Skip to Main Content

Paper Details

Targeting brain metastases in breast cancer.
Cancer Treat Rev
36
2022
BC, BMs, Brain metastases, HER2, ado-trastuzumab emtansine, advanced BC, brain metastases, breast cancer, cancer, central nervous system (CNS) disease, metastatic breast cancer, neratinib, patients, trastuzumab deruxtecan, tucatinib
Author NameAffiliation
Chiara CortiEuropean Institute of Oncology, IRCCS, University of Milan
Carmen CriscitielloEuropean Institute of Oncology, IRCCS, University of Milan
Nancy U LinDana-Farber Cancer Institute
Lisa A CareyUniversity of North Carolina Lineberger Comprehensive Cancer Center
Giuseppe CuriglianoEuropean Institute of Oncology, IRCCS, University of Milan
  • 1 - 5

Datasets

Release 1.2